Utility of whole exome sequencing analysis in differentiating intrapulmonary metastatic multiple ground-glass nodules (GGNs) from multiple primary GGNs

• Published in: International journal of clinical oncology Vol. 27; no. 5; pp. 871 - 881
• Main Authors: Zhou, Dong, Liu, Quan-Xing, Li, Man-yuan, Hou, Bin, Yang, Gui-xue, Lu, Xiao, Zheng, Hong, Jiang, Li, Dai, Ji-Gang
• Format: Journal Article
• Language: English
• Published: Singapore Springer Nature Singapore 01.05.2022; Springer Nature B.V
• Subjects: Cancer Research; Cloning; Copy number; Genomics; Humans; Lung cancer; Lung Neoplasms - pathology; Medicine; Medicine & Public Health; Metastases; Metastasis; Mutation; Neoplasms, Multiple Primary; Oncology; Original; Original Article; Patients; Retrospective Studies; Sequence analysis; Surgical Oncology; Tomography, X-Ray Computed; Whole Exome Sequencing; Multiple ground-glass nodule (GGN); Clone evolution analysis; Lung cancer; Whole exome sequencing (WES)
• ISSN: 1341-9625; 1437-7772
• DOI: 10.1007/s10147-022-02134-8

Purpose Clinical evidence of metastasis with ground-glass nodules (GGNs) has been reported, including pulmonary metastasis and distant metastasis. However, the clonal relationships of multiple GGNs at the genetic level remain unclear. Experimental design Sixty tissue specimens were obtained from 19 patients with multiple GGN lung cancer who underwent surgery in 2019. Whole exome sequencing (WES) was performed on tissue samples, and genomic profiling and clone evolution analysis were conducted to investigate the genetic characteristics and clonality of multiple GGNs. Results A total of 15,435 nonsynonymous mutations were identified by WES, and GGNs with shared nonsynonymous mutations were observed in seven patients. Copy number variant (CNV) analysis showed that GGNs in ten patients had at least one shared arm-level CNV. Mutational spectrum analysis showed that GGNs in three patients had similar six substitution profiles and GGNs in fou patients had similar 96 substitution profiles. According to the clone evolution analysis, we found that GGNs in five patients had shared clonal driver gene mutations. Taken together, we identified that 5 patients may have multiple primary GGNs without any similar genetic features, 2 patients may have intrapulmonary metastatic GGNs with ≥ 3 similar genetic features, and the other 12 patients cannot be determined due to insufficient evidences in our cohort. Conclusions Our findings suggest that the intrapulmonary metastasis exist in multiple GGNs, but the number of GGNs was not associated with the probability of metastasis. Application of genomic profiling may prove to be important to precise management of patients with multiple GGNs.